Transformation of a MGUS to Overt Multiple Myeloma: the Possible Role of a Pituitary Macroadenoma Secreting High Levels of Insulin-like Growth Factor 1 (IGF-1)
Overview
Authors
Affiliations
We present a female patient with monoclonal gammopathy of undetermined significance who has remained stable for five years but evolved to overt myeloma in strict temporal relationship with the diagnosis of GH-secreting pituitary macroadenoma. IGF-I serum levels correlated with serum and urine M component. Since the in vitro role of IGF-I on proliferation and survival of normal and neoplastic plasma cells has been recently emphasized, the pathogenetic link between acromegaly and transformation of gammopathy to overt myeloma in this case is discussed.
Multiple myeloma in a patient with acromegaly.
Kang Y, Choi J, Lee M, Ahn A, Park C, Chang K Endocrinol Metab (Seoul). 2014; 30(1):110-5.
PMID: 25491781 PMC: 4384674. DOI: 10.3803/EnM.2015.30.1.110.
The resistance mechanisms of proteasome inhibitor bortezomib.
Lu S, Wang J Biomark Res. 2013; 1(1):13.
PMID: 24252210 PMC: 4177604. DOI: 10.1186/2050-7771-1-13.
Kuhn D, Berkova Z, Jones R, Woessner R, Bjorklund C, Ma W Blood. 2012; 120(16):3260-70.
PMID: 22932796 PMC: 3476538. DOI: 10.1182/blood-2011-10-386789.
Zoppoli G, Bianchi F, Bruzzone A, Calvia A, Oneto C, Passalia C Pituitary. 2011; 15(2):209-14.
PMID: 21503687 DOI: 10.1007/s11102-011-0311-6.
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.
Balakumaran A, Robey P, Fedarko N, Landgren O Expert Rev Mol Diagn. 2010; 10(4):465-80.
PMID: 20465501 PMC: 2945699. DOI: 10.1586/erm.10.31.